RhumbLine Advisers’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,095
| Closed | -$14.3K | – | 4267 |
|
|
2024
Q2 | $14.3K | Sell |
1,095
-8,507
| -89% | -$111K | ﹤0.01% | 3924 |
|
|
2024
Q1 | $217K | Buy |
9,602
+395
| +4% | +$8.95K | ﹤0.01% | 3139 |
|
|
2023
Q4 | $119K | Sell |
9,207
-3
| -0% | -$39 | ﹤0.01% | 3392 |
|
|
2023
Q3 | $185K | Buy |
9,210
+238
| +3% | +$4.78K | ﹤0.01% | 3200 |
|
|
2023
Q2 | $241K | Buy |
8,972
+2,019
| +29% | +$54.2K | ﹤0.01% | 3141 |
|
|
2023
Q1 | $406K | Buy |
6,953
+370
| +6% | +$21.6K | ﹤0.01% | 2511 |
|
|
2022
Q4 | $336K | Sell |
6,583
-66
| -1% | -$3.37K | ﹤0.01% | 2633 |
|
|
2022
Q3 | $545K | Buy |
6,649
+554
| +9% | +$45.4K | ﹤0.01% | 2460 |
|
|
2022
Q2 | $412K | Buy |
6,095
+820
| +16% | +$55.4K | ﹤0.01% | 2594 |
|
|
2022
Q1 | $583K | Sell |
5,275
-1,039
| -16% | -$115K | ﹤0.01% | 2353 |
|
|
2021
Q4 | $609K | Sell |
6,314
-99
| -2% | -$9.55K | ﹤0.01% | 2427 |
|
|
2021
Q3 | $560K | Sell |
6,413
-1,966
| -23% | -$172K | ﹤0.01% | 2496 |
|
|
2021
Q2 | $1.3M | Buy |
8,379
+317
| +4% | +$49.1K | ﹤0.01% | 2133 |
|
|
2021
Q1 | $1.27M | Sell |
8,062
-252
| -3% | -$39.8K | ﹤0.01% | 2096 |
|
|
2020
Q4 | $1.93M | Buy |
8,314
+200
| +2% | +$46.4K | ﹤0.01% | 1861 |
|
|
2020
Q3 | $1.78M | Sell |
8,114
-1,243
| -13% | -$272K | ﹤0.01% | 1743 |
|
|
2020
Q2 | $2.66M | Buy |
9,357
+939
| +11% | +$267K | ﹤0.01% | 1572 |
|
|
2020
Q1 | $2.43M | Buy |
8,418
+170
| +2% | +$49K | 0.01% | 1442 |
|
|
2019
Q4 | $2.37M | Buy |
8,248
+521
| +7% | +$150K | ﹤0.01% | 1705 |
|
|
2019
Q3 | $1.12M | Buy |
7,727
+29
| +0.4% | +$4.19K | ﹤0.01% | 1991 |
|
|
2019
Q2 | $692K | Sell |
7,698
-1,139
| -13% | -$102K | ﹤0.01% | 2227 |
|
|
2019
Q1 | $774K | Buy |
8,837
+2,582
| +41% | +$226K | ﹤0.01% | 2145 |
|
|
2018
Q4 | $879K | Buy |
6,255
+3,411
| +120% | +$479K | ﹤0.01% | 2071 |
|
|
2018
Q3 | $726K | Sell |
2,844
-178
| -6% | -$45.4K | ﹤0.01% | 2133 |
|
|
2018
Q2 | $770K | Buy |
3,022
+785
| +35% | +$200K | ﹤0.01% | 2128 |
|
|
2018
Q1 | $450K | Buy |
2,237
+65
| +3% | +$13.1K | ﹤0.01% | 2252 |
|
|
2017
Q4 | $313K | Sell |
2,172
-2,842
| -57% | -$410K | ﹤0.01% | 2450 |
|
|
2017
Q3 | $826K | Buy |
5,014
+27
| +0.5% | +$4.45K | ﹤0.01% | 2069 |
|
|
2017
Q2 | $677K | Buy |
4,987
+401
| +9% | +$54.4K | ﹤0.01% | 2157 |
|
|
2017
Q1 | $883K | Buy |
4,586
+266
| +6% | +$51.2K | ﹤0.01% | 1991 |
|
|
2016
Q4 | $609K | Sell |
4,320
-1,119
| -21% | -$158K | ﹤0.01% | 2120 |
|
|
2016
Q3 | $794K | Buy |
5,439
+1,142
| +27% | +$167K | ﹤0.01% | 1949 |
|
|
2016
Q2 | $433K | Buy |
4,297
+2,808
| +189% | +$283K | ﹤0.01% | 2283 |
|
|
2016
Q1 | $199K | Buy |
1,489
+6
| +0.4% | +$802 | ﹤0.01% | 2734 |
|
|
2015
Q4 | $295K | Buy |
1,483
+100
| +7% | +$19.9K | ﹤0.01% | 2592 |
|
|
2015
Q3 | $218K | Buy |
1,383
+81
| +6% | +$12.8K | ﹤0.01% | 2743 |
|
|
2015
Q2 | $531K | Buy |
1,302
+406
| +45% | +$166K | ﹤0.01% | 2284 |
|
|
2015
Q1 | $411K | Buy |
896
+192
| +27% | +$88.1K | ﹤0.01% | 2419 |
|
|
2014
Q4 | $395K | Buy |
704
+21
| +3% | +$11.8K | ﹤0.01% | 2420 |
|
|
2014
Q3 | $358K | Sell |
683
-18
| -3% | -$9.44K | ﹤0.01% | 2418 |
|
|
2014
Q2 | $490K | Buy |
+701
| New | +$490K | ﹤0.01% | 2283 |
|